The prediction of safety and efficacy of a new propranolol external medicine for Infantile Hemangioma.

○Eiji Sunaga

1:30 PM - 1:42 PM

[28G-pm01S] The prediction of safety and efficacy of a new propranolol external medicine for Infantile Hemangioma.

○Eiji Sunaga¹, Masashi Uchida^1,2, Hirokazu Takatsuka², Shingo Yamazaki², Soichi Monma³, Takaaki Suzuki^1,2, Itsuko Ishii^1,2 (1. Grad. Sch. Pharm Sci., Chiba Univ., 2. Division of pharmacy, Chiba Univ. Hosp., 3. Nissan Chemical Corp.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[28G-pm] In-house formulation/Drug information-2

[28G-pm01S] The prediction of safety and efficacy of a new propranolol external medicine for Infantile Hemangioma.

Password